Literature DB >> 9252606

Elevated levels of testosterone receptors in keloid tissue: an experimental investigation.

H P Schierle1, D Scholz, G Lemperle.   

Abstract

Testosterone-binding receptor protein analyses were performed in keloids of 24 patients. According to their clinical appearance (hyperemia, pain, rapid growth, etc.), the lesions were subdivided into regions of minor and major clinical keloid activity. Biopsies were taken from active and inactive parts of the keloids, respectively, as well as from normal adjacent skin. The mean receptor amount in femtomoles per milligrams of tissue was 0.046 for active (SD = 0.037), 0.038 for inactive keloidal lesions (SD = 0.032), and 0.012 for normal skin. The corresponding receptor amount per microgram of DNA was 3.356 fmol (SD = 2.171) for active, 2.077 fmol (SD = 1.427) for inactive keloidal, and 1.010 fmol (SD = 1.190) for normal tissue. Statistical evaluation was performed using a two-way analysis of variance, with the two factors being individual subject and type of tissue. When differences were found, then Tukey's comparison was done to assess where those differences were. Comparisons of the receptor amount per milligram of tissue significant at the 0.05 level revealed significant differences between active keloid tissue and normal skin tissue and inactive and normal tissue (p < 0.01) respectively, while different receptor amount per microgram of DNA was significant between active and inactive and active and normal tissue (p < 0.01). These data suggest that elevated androgen receptor levels exist in clinical active keloid tissue and that possible therapeutic means might include topical antiandrogen therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252606     DOI: 10.1097/00006534-199708000-00017

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

Review 1.  Prevention and treatment of excessive dermal scarring.

Authors:  Ingrid E Roseborough; Mark A Grevious; Raphael C Lee
Journal:  J Natl Med Assoc       Date:  2004-01       Impact factor: 1.798

2.  Management of keloid and hypertrophic scars.

Authors:  A S Edriss; J Mesták
Journal:  Ann Burns Fire Disasters       Date:  2005-12-31

Review 3.  Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

Authors:  Gerd G Gauglitz; Hans C Korting; Tatiana Pavicic; Thomas Ruzicka; Marc G Jeschke
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

4.  A pregnant patient with fetal distress with severe post burn contracture of anterior trunk and perineum: A surgeon's nightmare!

Authors:  Madhubari Vathulya; Meenakshi Joshi
Journal:  Indian J Plast Surg       Date:  2014 Sep-Dec

5.  Eruptive keloids associated with aromatase inhibitor therapy.

Authors:  Cathy Meade; Samantha Smith; Zaineb Makhzoumi
Journal:  JAAD Case Rep       Date:  2015-05-02

6.  Keloids: Which Types Can Be Excised without Risk of Recurrence? A New Clinical Classification.

Authors:  Gottfried Lemperle; Johannes Schierle; Kakubindi Eric Kitoga; Katja Kassem-Trautmann; Christoph Sachs; Arno Dimmler
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.